Globus Medical Reports Fourth Quarter and Full Year 2025 Results

AUDUBON, Pa., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology solutions company, today announced its financial results for the fourth quarter and year ended December 31, 2025.

GlobeNewsWire • 5 hours ago

GMED or MASI: Which Is the Better Value Stock Right Now?

Investors looking for stocks in the Medical - Instruments sector might want to consider either Globus Medical (GMED) or Masimo (MASI). But which of these two stocks is more attractive to value investors?

Zacks Investment Research • Feb 23, 2026

Wall Street's Insights Into Key Metrics Ahead of Globus Medical (GMED) Q4 Earnings

Beyond analysts' top-and-bottom-line estimates for Globus Medical (GMED), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2025.

Zacks Investment Research • Feb 19, 2026

Globus Medical Schedules Fourth Quarter and Full Year 2025 Earnings Release and Conference Call

AUDUBON, Pa., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the fourth quarter and full-year ended December 31, 2025 after the market close on Tuesday, February 24, 2026.

GlobeNewsWire • Feb 12, 2026

Globus Medical (GMED) to Report Q4 Results: Wall Street Expects Earnings Growth

Globus Medical (GMED) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research • Feb 12, 2026

Why Globus Medical (GMED) is a Top Growth Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks Investment Research • Feb 11, 2026

Here's Why Globus Medical (GMED) is a Strong Value Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks Investment Research • Feb 5, 2026

Steven Cress' Top 10 AI Stocks (Recap & Update)

The AI sector remains highly attractive, with top quant-rated stocks offering superior growth and fundamentals despite recent volatility and sharp pullbacks. Head of Quantitative Strategy at Seeking Alpha, Steven Cress, shares which AI stocks look best for this year.

Seeking Alpha • Feb 4, 2026

GMED vs. PEN: Which Stock Is the Better Value Option?

Investors looking for stocks in the Medical - Instruments sector might want to consider either Globus Medical (GMED) or Penumbra (PEN). But which of these two stocks is more attractive to value investors?

Zacks Investment Research • Feb 3, 2026

Here's Why Globus Medical (GMED) is a Strong Momentum Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks Investment Research • Jan 27, 2026